A detailed history of Mv Capital Management, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Mv Capital Management, Inc. holds 2 shares of ITCI stock, worth $167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 3 33.33%
Holding current value
$167
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$67.99 - $80.84 $67 - $80
-1 Reduced 33.33%
2 $0
Q2 2024

Aug 01, 2024

BUY
$64.76 - $79.84 $64 - $79
1 Added 50.0%
3 $0
Q1 2024

Apr 18, 2024

BUY
$64.37 - $75.65 $64 - $75
1 Added 100.0%
2 $0
Q4 2023

Jan 29, 2024

BUY
$46.37 - $73.65 $46 - $73
1 New
1 $0

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.